Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk - PubMed (original) (raw)
. 2006 Jul 4;48(1):193-202.
doi: 10.1016/j.jacc.2006.03.042. Epub 2006 May 5.
Affiliations
- PMID: 16814667
- DOI: 10.1016/j.jacc.2006.03.042
Free article
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk
Michael Joner et al. J Am Coll Cardiol. 2006.
Free article
Abstract
Objectives: This study examined human drug-eluting stents (DES) to determine the long-term effects of these stents on coronary arterial healing and identified mechanisms underlying late stent thrombosis (LST).
Background: Although DES reduce the need for repeat revascularization compared with bare-metal stents (BMS), data suggest the window of thrombotic risk for Cypher (Cordis Corp., Miami Lakes, Florida) and Taxus (Boston Scientific Corp., Natick, Massachusetts) DES extends far beyond that for BMS.
Methods: From a registry of 40 autopsies of DES (68 stents), 23 DES cases of >30 days duration were compared with 25 matched autopsies of BMS implantation. Late stent thrombosis was defined as an acute thrombus within a stent >30 days old.
Results: Of 23 patients with DES >30 days old, 14 had evidence of LST. Cypher and Taxus DES showed greater delayed healing characterized by persistent fibrin deposition (fibrin score 2.3 +/- 1.1 vs. 0.9 +/- 0.8, p = 0.0001) and poorer endothelialization (55.8 +/- 26.5%) compared with BMS (89.8 +/- 20.9, p = 0.0001). Moreover, DES with LST showed more delayed healing compared with patent DES. In 5 of 14 patients suffering LST, antiplatelet therapy had been withdrawn. Additional procedural and pathologic risk factors for LST were: 1) local hypersensitivity reaction; 2) ostial and/or bifurcation stenting; 3) malapposition/incomplete apposition; 4) restenosis; and 5) strut penetration into a necrotic core.
Conclusions: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration. The cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
Comment in
- Drug-eluting stent thrombosis: increasingly recognized but too frequently overemphasized.
Colombo A, Corbett SJ. Colombo A, et al. J Am Coll Cardiol. 2006 Jul 4;48(1):203-5. doi: 10.1016/j.jacc.2006.04.040. Epub 2006 May 5. J Am Coll Cardiol. 2006. PMID: 16814668 No abstract available.
Similar articles
- Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Finn AV, et al. Circulation. 2007 May 8;115(18):2435-41. doi: 10.1161/CIRCULATIONAHA.107.693739. Epub 2007 Apr 16. Circulation. 2007. PMID: 17438147 - Vascular pathology of drug-eluting stents.
Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Herz. 2007 Jun;32(4):274-80. doi: 10.1007/s00059-007-2997-9. Herz. 2007. PMID: 17607533 Review. - Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Marzocchi A, et al. Circulation. 2007 Jun 26;115(25):3181-8. doi: 10.1161/CIRCULATIONAHA.106.667592. Epub 2007 Jun 11. Circulation. 2007. PMID: 17562952 - Pathology of drug-eluting stents: implications for coronary intervention.
Finn AV, Nakazawa G, Virmani R. Finn AV, et al. Indian Heart J. 2007 Mar-Apr;59(2 Suppl B):B41-9. Indian Heart J. 2007. PMID: 19153436 - Late coronary stent thrombosis.
Thuesen L, Holm NR. Thuesen L, et al. Minerva Med. 2010 Feb;101(1):25-33. Minerva Med. 2010. PMID: 20228718 Review.
Cited by
- Value of a new post-procedural intravascular ultrasound score in predicting target vessel revascularization after coronary drug-eluting stents implantation.
Xu K, Han YL, Jing QM, Wang SL, Ma YY, Wang XZ, Wang G, Wang ZL. Xu K, et al. J Zhejiang Univ Sci B. 2012 Aug;13(8):624-30. doi: 10.1631/jzus.B1201002. J Zhejiang Univ Sci B. 2012. PMID: 22843182 Free PMC article. Clinical Trial. - A case of stent thrombosis occurred at 5 years after sirolimus-eluting stent implantation.
Kim SA, Lim SY. Kim SA, et al. Chonnam Med J. 2011 Aug;47(2):124-6. doi: 10.4068/cmj.2011.47.2.124. Epub 2011 Aug 31. Chonnam Med J. 2011. PMID: 22111073 Free PMC article. - The late-phase inflammatory response after drug-eluting stent implantation.
Taguchi I, Yoneda S, Abe S, Toyoda S, Nasuno T, Nishino S, Kageyama M, Tokura M, Ogawa M, Node K, Inoue T. Taguchi I, et al. Heart Vessels. 2014 Mar;29(2):213-9. doi: 10.1007/s00380-013-0357-7. Epub 2013 May 7. Heart Vessels. 2014. PMID: 23649933 - Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends.
Tan L, Wang X, Yuan K, Yin T, Du R, Shen L, Zhu Z, Yu S, Zhang H, Wang G. Tan L, et al. Bioact Mater. 2022 Nov 11;23:170-186. doi: 10.1016/j.bioactmat.2022.09.009. eCollection 2023 May. Bioact Mater. 2022. PMID: 36406256 Free PMC article. Review. - Giant coronary artery aneurysm following implantation of Endeavour stent presenting with fever.
Saran RK, Dwivedi SK, Puri A, Sethi R, Agarwal SK. Saran RK, et al. Indian Heart J. 2012 Mar-Apr;64(2):198-9. doi: 10.1016/S0019-4832(12)60061-3. Epub 2012 Apr 28. Indian Heart J. 2012. PMID: 22572500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources